Jennison Associates

Jennison Associates

Jennison Associates

Active fundamental manager with single focus, strong investment culture and superior investment returns across capabilities for 45 years
Follow us
Alexa global traffic share
Twitter followers
Latest investments Show all
$75,000,000
Venture capital (Series B)
Ovid Therapeutics
$120,000,000
Venture capital (Series B)
Editas Medicine
Team Size
1–10
Employees
Past year's investments

Jennison Associates participated in fewer than 3 rounds over the past year

Latest rounds
  • Ovid Therapeutics: Venture capital (Series B) ($75M)
  • Editas Medicine: Venture capital (Series B) ($120M)
  • Unum Therapeutics: Venture capital (Series B) ($65M)